These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36050862)

  • 1. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365-72.
    Sun X; Wang Q; Shi Q
    Clin Chem Lab Med; 2022 Oct; 60(11):e243. PubMed ID: 36050862
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365-72.
    Smith TP; Fahie-Wilson MN
    Clin Chem Lab Med; 2022 Oct; 60(11):e244-e245. PubMed ID: 36052827
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
    McCudden CR; Sharpless JL; Grenache DG
    Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactin: From laboratory to clinical practice.
    Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
    Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
    Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
    Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report.
    Cattaneo FA; Fahie-Wilson MN
    J Neurosurg; 2001 Aug; 95(2):334-7. PubMed ID: 11780906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia.
    Alfonso A; Rieniets KI; Vigersky RA
    Endocr Pract; 2006; 12(3):275-80. PubMed ID: 16772199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
    Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
    Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the Editor relating to Clin Chem Lab Med 2018;56(7):1090-1099.
    Infantino M; Grossi V; Benucci M; Manfredi M
    Clin Chem Lab Med; 2019 Mar; 57(4):e45-e46. PubMed ID: 30138111
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
    Overgaard M; Pedersen SM
    Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia.
    Chahal J; Schlechte J
    Pituitary; 2008; 11(2):141-6. PubMed ID: 18404389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.